ldi for crohn's disease and irritable bowel disorders- low dose immunotherapy
Published 2 months ago • 148 plays • Length 13:10Download video MP4
Download video MP3
Similar videos
-
1:39:31
pandas/pans & low-dose immunotherapy - parent q&a with dr. ty vincent
-
watch drs. pal, tannir, & zhang discuss #rcc updates from #ikcsna24 - bit.ly/louisville24y
-
44:32
interventional immunotherapy: transforming the treatment of solid tumors
-
1:08
clinically relevant side effects of bite immunotherapy and other t-cell therapies
-
6:21
the biggest benefit of taking t2 thyroid hormone
-
2:19
potassium and vitamin b12 balance explained by dr.berg!!
-
7:31
mixed mania treatment: lithium or valproate as add-on therapy?
-
1:00
t2 here’s how you can know if you were low in it and what you can do to safely raise it.
-
1:54
the potential role of cellular therapies and vaccines in the future treatment of mpns
-
0:42
there are immunotherapies that cure cancer
-
0:54
challenges impacting treatment of cutaneous and peripheral t-cell lymphomas
-
1:41
dual anti–ctla-4 and anti–pd-1 blockade in rare tumors (dart) swog s1609
-
2:47
the state of immunotherapy
-
0:42
exploring the potential role of immunotherapy in ph-like all and novel targets of interest
-
2:20
the risk of t-cell malignancies associated with car t-cell therapy
-
3:01
managing the side effects of immunotherapy: a vital consideration
-
1:58
t cell immunotherapy explained
-
1:26
impact of recent bendamustine treatment before apheresis on car-t therapy outcomes in lbcl
-
1:10
immunotherapy and its dependence on t-cells
-
1:29
aml immunotherapy: patients need to be well informed
-
0:53
anti-cd7 car-t therapy for t-all/lbl